MedPath

Portia

(levonorgestrel and ethinyl estradiol tablets USP)

Approved
Approval ID

c78b236b-85c4-4258-a524-cea08775100c

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Mar 12, 2025

Manufacturers
FDA

Teva Pharmaceuticals USA, Inc.

DUNS: 001627975

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Levonorgestrel and Ethinyl Estradiol

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0555-9020
Application NumberANDA075866
Product Classification
M
Marketing Category
C73584
G
Generic Name
Levonorgestrel and Ethinyl Estradiol
Product Specifications
Effective DateMarch 12, 2025
FDA Product Classification

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Portia - FDA Drug Approval Details